1887

Journal of Medical Microbiology logo

Volume 68, Issue 9

Development of a nano-gold immunodiagnostic assay for rapid on-site detection of invasive aspergillosis Free

Abstract

Timely detection of invasive aspergillosis (IA) caused by fungal pathogens, i.e. and , in immunocompromised patients is crucial in preventing high mortality.

To develop a simple immunoassay for the detection of galactomannan (GM), an IA biomarker.

. GM from and clinical strains was purified and characterized by X-ray diffraction, IR spectroscopy and C/H nuclear magnetic resonance (NMR) for polyclonal antibody (pAb) production in rabbits. An enzyme-linked immunosorbent assay (ELISA) was standardized using concanavalin A to capture GM and pAbs to detect it. Gold nanoparticles (AuNPs) were synthesized and conjugated to pAbs for the development of a dot-blot immunoassay. The developed dot-blot was evaluated with 109 clinical serum and bronchoalveolar lavage samples.

. Spectroscopy studies characterized the -galactofuranosyl groups of GM responsible for the immune response and generation of pAbs. The ELISA employing pAbs showed a sensitivity of 1 ng ml for GM. Furthermore, a sensitive, visual, rapid dot-blot assay developed by the conjugation of pAbs to AuNPs (~24±5 nm size, −36±2 mV zeta potential) had a detection limit of 1 pg ml in serum. The pAbs interacted with spp. but did not cross-react with other fungal pathogen genera such as and . Evaluation of the dot-blot with 109 clinical samples showed high sensitivity (80 %) and specificity (93.2 %), with an overall assay accuracy of 89%.

. The developed nano-gold immunodiagnostic assay has immense potential for practical use in rapid, specific and sensitive on-site diagnosis of IA, even under resource-limited settings.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Aspergillus , dot blot assay , galactomannan , gold nanoparticles and invasive aspergillosis
© 2019 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001040
2019-09-01
2023-11-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/9/1341.html?itemId=/content/journal/jmm/10.1099/jmm.0.001040&mimeType=html&fmt=ahah

References

  1. Barton RC. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica 2013; 2013:1–29 [View Article]
     [Google Scholar]
  2. Chakrabarti A, Chatterjee SS, Das A, Shivaprakash MR. Invasive aspergillosis in developing countries. Med Mycol 2011; 49:S35–S47 [View Article]
     [Google Scholar]
  3. Bao Z, Chen H, Zhou M, Shi G, Li Q et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case report and review of the literature. Oncotarget 2017; 8:38069–38074 [View Article]
     [Google Scholar]
  4. Pal M. Morbidity and mortality due to fungal infections. J Appl Microbiol Biochem 2017; 1:1–3
     [Google Scholar]
  5. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG et al. Hidden killers: human fungal infections. Sci Transl Med 2012; 4:165rv13–16519 [View Article]
     [Google Scholar]
  6. Bongomin F, Gago S, Oladele R, Denning D. Global and Multi-National prevalence of fungal Diseases—Estimate precision. J Fungi 2017; 3:57–29 [View Article]
     [Google Scholar]
  7. The Fungal Infection Trust 2017; How common are fungal diseases? in proceedings of the fungal research trust 20th anniversary Meeting-2011. www.fungalinfectiontrust.org/wp-content/uploads/2015/12/How-Common-are-FungalDiseases-v12.2.pdf
  8. Chakrabarti A, Chatterjee SS, Shivaprakash MR. Overview of opportunistic fungal infections in India. Nippon Ishinkin Gakkai Zasshi 2008; 49:165–172 [View Article]
     [Google Scholar]
  9. Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus . Med Mycol 2009; 47:S261–S270 [View Article]
     [Google Scholar]
  10. Dagenais TRT, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 2009; 22:447–465 [View Article]
     [Google Scholar]
  11. Atchade E, Jean-Baptiste S, Houzé S, Chabut C, Massias L et al. Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation. Med Mycol Case Rep 2017; 17:4–7 [View Article]
     [Google Scholar]
  12. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of Cancer/Invasive fungal infections cooperative group and the National Institute of allergy and infectious diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46:1813–1821 [View Article]
     [Google Scholar]
  13. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002; 15:465–484 [View Article]
     [Google Scholar]
  14. Klont RR, Meis JF, Verweij PE. Critical assessment of issues in the diagnosis of invasive aspergillosis. Clin Microbiol Infect 2001; 7:32–37 [View Article]
     [Google Scholar]
  15. Thornton CR. Chapter 6 - Detection of invasive aspergillosis. Adv Appl Microbiol 2010; 70:187–216
     [Google Scholar]
  16. Cuenca-Estrella M, Bernal-Martinez L, Buitrago MJ, Castelli MV, Gomez-Lopez A et al. Update on the epidemiology and diagnosis of invasive fungal infection. Int J Antimicrob Agents 2008; 32:S143–S147 [View Article]
     [Google Scholar]
  17. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5:609–622 [View Article]
     [Google Scholar]
  18. Stynen D, Sarfati J, Goris A, Prévost MC, Lesourd M et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60:2237–2245
     [Google Scholar]
  19. Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4:349–357 [View Article]
     [Google Scholar]
  20. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P et al. False-Positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38:913–916 [View Article]
     [Google Scholar]
  21. Verweij PE. Advances in diagnostic testing. Med Mycol 2005; 43:121–124 [View Article]
     [Google Scholar]
  22. Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008; 15:1095–1105 [View Article]
     [Google Scholar]
  23. Hurst SF, Reyes GH, McLaughlin DW, Reiss E, Morrison CJ. Comparison of commercial latex agglutination and sandwich enzyme immunoassay with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis. Clin and Diagn Lab Immunol 2000; 7:477–485
     [Google Scholar]
  24. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature Physical Science 1973; 241:20–22 [View Article]
     [Google Scholar]
  25. Hermanson GT. Bioconjugate techniques. Chapter 24: Preparation of Colloidal Gold-Labeled Proteins, 2nd ed. USA: Elsevier Inc; 2007 pp 924–935
     [Google Scholar]
  26. Thornton CR, Johnson G, Agrawal S. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp 2012; 61:1–5
     [Google Scholar]
  27. Little TA. Method validation essentials, limit of blank, limit of detection, and limit of quantitation. BioPharm International in press 2015; 28:48–51
     [Google Scholar]
  28. Jaedicke KM, Taylor JJ, Preshaw PM. Validation and quality control of ELISAs for the use with human saliva samples. J Immunol Methods 2012; 377:62–65 [View Article]
     [Google Scholar]
  29. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20:37–46 [View Article]
     [Google Scholar]
  30. Latgé JP, Debeaupuis JP, Moutaouakil M, Diaquin M, Sarfati J et al. Galactomannan and the circulating antigens of Aspergillus fumigatus . In Latgé JP, Boucias D. (editors) Fungal Cell Wall and Immune Response 53, NATO ASI Series (Series H: Cell Biology). Berlin, Heidelberg: Springer; 1991 pp 143–145
     [Google Scholar]
  31. Reiss E, Lehmann PF. Galactomannan antigenemia in invasive aspergillosis. Infect Immun 1979; 25:357–365
     [Google Scholar]
  32. Martins JT, Cerqueira MA, Bourbon AI, Pinheiro AC, Souza BWS et al. Synergistic effects between κ-carrageenan and locust bean gum on physicochemical properties of edible films made thereof. Food Hydrocoll 2012; 29:280–289 [View Article]
     [Google Scholar]
  33. Cerqueira MA, Souza BWS, Simões J, Teixeira JA, Domingues MRM et al. Structural and thermal characterization of galactomannans from non-conventional sources. Carbohydr Polym 2011; 83:179–185 [View Article]
     [Google Scholar]
  34. Figueiro S, GOES J, MOREIRA R, Sombra A. On the physico-chemical and dielectric properties of glutaraldehyde crosslinked galactomannan–collagen films. Carbohydr Polym 2004; 56:313–320 [View Article]
     [Google Scholar]
  35. Latgé JP, Kobayashi H, Debeaupuis JP, Diaquin M, Sarfati J et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus . Infect Immun 1994; 62:5424–5433
     [Google Scholar]
  36. M. Barreto-Berter E, R. Travassos L, Gorin PAJ. Chemical structure of the d-galacto-d-mannan component from hyphae of Aspergillus niger and other Aspergillus spp . Carbohydr Res 1980; 86:273–285 [View Article]
     [Google Scholar]
  37. Barreto-Bergter E, A.J. Gorin P, Travassos LR. Cell constituents of mycelia and conidia of Aspergillus fumigatus . Carbohydr Res 1981; 95:205–217 [View Article]
     [Google Scholar]
  38. Unkefer CJ, Gander JE. The 5-O-β-D-galactofuranosyl-containing glycopeptide from Penicillium charlesii. Carbon 13 nuclear magnetic resonance studies. J Biol Chem 1979; 254:12131–12135
     [Google Scholar]
  39. Unkefer CJ, Gander JE. The 5-O-beta-D-galactofuranosyl-containing peptidophosphogalactomannan of Penicillium charlesii. Characterization of the mannan by 13C NMR spectroscopy. J Biol Chem 1990; 265:685–689
     [Google Scholar]
  40. Kobayashi H, Shibata N, Mitobe H, Ohkubo Y, Suzuki S. Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch Biochem Biophys 1989; 272:364–375 [View Article]
     [Google Scholar]
  41. Haido RM, Silva MH, Ejzemberg R, Leitão EA, Hearn VM et al. Analysis of peptidogalactomannans from the mycelial surface of Aspergillus fumigatus . Med Mycol 1998; 36:313–321 [View Article]
     [Google Scholar]
  42. Krylov VB, Argunov DA, Solovev AS, Petruk MI, Gerbst AG et al. Synthesis of oligosaccharides related to galactomannans from Aspergillus fumigatus and their NMR spectral data. Org Biomol Chem 2018; 16:1188–1199 [View Article]
     [Google Scholar]
  43. Guo S, Mao W, Yan M, Zhao C, Li N et al. Galactomannan with novel structure produced by the coral endophytic fungus Aspergillus ochraceus . Carbohydr Polym 2014; 105:325–333 [View Article]
     [Google Scholar]
  44. Goldstein IJ, Hollerman CE, Smith EE. Protein-Carbohydrate interaction. II. inhibition studies on the interaction of concanavalin A with polysaccharides. Biochemistry 1965; 4:876–883 [View Article]
     [Google Scholar]
  45. Sharon N, Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science 1972; 177:949–959 [View Article]
     [Google Scholar]
  46. Hardman KD, Agarwal RC, Freiser MJ. Manganese and calcium binding sites of concanavalin A. J Mol Biol 1982; 157:69–86 [View Article]
     [Google Scholar]
  47. Bioanalytical method Validation- guidance for industry. FDA 2018 https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf
     [Google Scholar]
  48. Chai LYA, Kullberg B-J, Johnson EM, Teerenstra S, Khin LW et al. Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol 2012; 50:2330–2336 [View Article]
     [Google Scholar]
  49. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001; 91:311–318 [View Article]
     [Google Scholar]
  50. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. JCO 1997; 15:139–147 [View Article]
     [Google Scholar]
  51. Becker MJ, de Marie S, Willemse D, Verbrugh HA, Bakker-Woudenberg IA. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 2000; 38:1434–1438
     [Google Scholar]
  52. Chindamporn A, Chakrabarti A, Li R, Sun PL, Tan BH et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia fungal Working Group (AFWG) initiative. Med Mycol 2017; 0:1–10
     [Google Scholar]
  53. Chen P, Gates-Hollingsworth M, Pandit S, Park A, Montgomery D et al. Paper-based vertical flow immunoassay (VFI) for detection of bio-threat pathogens. Talanta 2019; 191:81–88 [View Article]
     [Google Scholar]
  54. Ramachandran S, Singhal M, McKenzie KG, Osborn JL, Arjyal A et al. A rapid, multiplexed, high-throughput flow-through membrane immunoassay: a convenient alternative to ELISA. Diagnostics 2013; 3:244–260 [View Article]
     [Google Scholar]
  55. Notermans S, Veeneman GH, van Zuylen CW, Hoogerhout P, van Boom JH. (1→5)-linked beta-D-galactofuranosides are immunodominant in extracellular polysaccharides of Penicillium and Aspergillus species. Mol Immunol 1988; 25:975–979 [View Article]
     [Google Scholar]
  56. Bennett JE, Bhattacharjee AK, Glaudemans CP. Galactofuranosyl groups are immunodominant in Aspergillus fumigatus galactomannan. Mol Immunol 1985; 22:251–254 [View Article]
     [Google Scholar]
  57. Feng X, Wen H, Zhang Z, Chen X, Ma X et al. Dot immunogold filtration assay (DIGFA) with multiple native antigens for rapid serodiagnosis of human cystic and alveolar echinococcosis. Acta Trop 2010; 113:114–120 [View Article]
     [Google Scholar]
  58. Kalita P, Dasgupta A, Sritharan V, Gupta S. Nanoparticle-Drug bioconjugate as dual functional affinity ligand for rapid point-of-care detection of endotoxin in water and serum. Anal Chem 2015; 87:11007–11012 [View Article]
     [Google Scholar]
  59. Delaney KP, Branson BM, Uniyal A, Phillips S, Candal D et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis 2011; 52:257–263 [View Article]
     [Google Scholar]
  60. Huang JY, Lin HT, Chen TH, Chen CA, Chang HT et al. Signal amplified gold nanoparticles for cancer diagnosis on paper-based analytical devices. ACS Sens 2018; 3:174–182 [View Article]
     [Google Scholar]
  61. Eamsobhana P, Gan XX, Ma A, Wang Y, Wanachiwanawin D et al. Dot immunogold filtration assay (DIGFA) for the rapid detection of specific antibodies against the rat lungworm Angiostrongylus cantonensis (Nematoda: Metastrongyloidea) using purified 31-kDa antigen. J Helminthol 2014; 88:396–401 [View Article]
     [Google Scholar]
  62. Pandey SK, Suri CR, Chaudhry M, Tiwari RP, Rishi P. A gold nanoparticles based immuno-bioprobe for detection of Vi capsular polysaccharide of Salmonella enterica serovar Typhi. Mol Biosyst 2012; 8:1853–1860 [View Article]
     [Google Scholar]
  63. Zhou Y, Tian XL, Li YS, Pan FG, Zhang YY et al. An enhanced ELISA based on modified colloidal gold nanoparticles for the detection of Pb(II). Biosens Bioelectron 2011; 26:3700–3704 [View Article]
     [Google Scholar]
  64. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35:257–260
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001040
Loading
Development of a nano-gold immunodiagnostic assay for rapid on-site detection of invasive aspergillosis
J. Med. Microbiol. 68, 1341 (2019); https://doi.org/10.1099/jmm.0.001040
/content/journal/jmm/10.1099/jmm.0.001040
/content/journal/jmm/10.1099/jmm.0.001040
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error